Skip to main content
. 2023 Jun 9;15(12):3126. doi: 10.3390/cancers15123126
AGEP Acute Generalized Exanthematous Pustulosis
BRAFi BRAF-inhibitors
BSA Body Surface Area
CTLA-4 T lymphocyte-associated antigen-4
DRESS Drug Reaction with Eosinophilia and Systemic Symptoms
EGFR Epidermal Growth Factor Receptor Inhibitors
ICIs Immune Checkpoint-Inhibitors
IGF-1 Insulin-like Growing Factor-1
irAE Immune-related Adverse Event
MAPK Mitogen-activated Protein Kinase
MEKi MEK-inhibitors
NMSC Nonmelanoma Skin Cancer
PD-1 Programmed Cell Death Protein 1
PD-L1 Programmed Death Ligand 1
PTCH1 Patched Homologue 1
SCC Squamous Cell Carcinomas
SMO Smoothened Homologue